Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2296 of 6351
-
New pain tablet could replace IV opioids in ERs
Symptom relief Recruiting nowPain is a common reason for emergency department (ED) visits. However, studies suggest that emergency physicians may not always provide optimal analgesic treatment due to various factors, such as time constraints, demographic factors like gender and age, and concerns about opioid…
Phase 3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New weekly shot shows promise for weight loss in type 2 diabetes
Disease control CompletedThe main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes.
Phase 2 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Could a daily pill boost growth in kids with hypochondroplasia?
Disease control By invitation onlyACCEL2/3 is a Phase 2/3 study. The purpose of the Phase 2 portion of the study (ACCEL2/3) is to evaluate the efficacy and safety of infigratinib in children with hypochondroplasia (HCH) receiving infigratinib at one of two doses, who have completed at least 26 weeks of participat…
Phase 2/3 • Sponsor: QED Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Decoding Immunotherapy's liver side effect to keep cancer treatment on track
Knowledge-focused Recruiting nowBackground and Study Rationale Immune checkpoint inhibitors (ICI) are a breakthrough cancer treatment that boosts the immune system to fight tumors. While effective, they can cause immune-related side effects, including liver inflammation (ICI-induced hepatitis or CHILI), which a…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a common nausea drug tame a dangerous heart rhythm?
Disease control Recruiting now"Afib" is a common irregular heartbeat. Afib can cause stroke, blood clots, dementia and death. Medicines used to treat Afib often do not work well and can cause serious side effects. Clinicians need medicines that work better for Afib. Medicines for Afib work by blocking a curre…
Phase 4 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study tests Uterus-Saving approach for dangerous pregnancy condition
Disease control Recruiting nowThis study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy. However, accumulating data sh…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New pill combo aims to crush high cholesterol
Disease control CompletedThis is a multicenter, randomized, double-blind, active-controlled, parallel, phase III clinical trial to evaluate the efficacy and safety of combination therapy of DW5421A/DW5421B versus monotherapy of DW5421A in patients with primary hypercholesterolemia or mixed dyslipidemia.
Phase 3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can a deeper nerve block ease pain after breast surgery?
Symptom relief CompletedThe main purpose of this study is to compare the effectiveness of two different regional anesthesia techniques for pain management after oncological breast surgeries. The researchers will compare the combined (superficial and deep) serratus anterior plane block with the deep serr…
Sponsor: SBU Ankara Egitim ve Arastirma Hastanesi • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Bladder cancer chemotherapy comes home: new trial tests convenience and safety
Symptom relief Recruiting nowThis phase Ib/II trial compares the safety, tolerability and acceptability of intravesical chemotherapy given at home to in-clinic administration in patients with non-muscle invasive bladder cancer. Chemotherapy drugs, such as bacillus Calmette-Guerin (BCG), gemcitabine, docetaxe…
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Could light make cochlear implants hear better?
Knowledge-focused By invitation onlyNeural stimulation with photons has been proposed for a next generation of cochlear implants (CIs). The potential benefit of photonic over electrical stimulation is its spatially selective activation of small populations of spiral ganglion neurons (SGNs). Stimulating smaller neur…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Immunotherapy before surgery: which next step works best for lung cancer?
Knowledge-focused Recruiting nowThe goal of this observational study is to learn about the long-term effects of neoadjuvant immunotherapy in patients with lung cancer. The main questions it aims to answer are: * Does pneumonectomy bring more benefits for pateints than lobectomy? * Does surgery bring more benef…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:25 UTC
-
New kidney stone surgery could be safer and more effective
Disease control By invitation onlyThe goal of this clinical trial is to learn if the Vortex Intelligence Stone Optimized Removal (VISOR) works safely and effectively to treat kidney stones that are 2 to 4 centimeters in size in kidney. This study will also look at how VISOR compares to the standard surgery, percu…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 26, 2026 16:15 UTC
-
New Egg-Maturing solution could boost IVF success
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of using Fertilo for In vitro maturation (IVM) in participants 18-35 years of age. The main question it aims to answer is whether the use of Fertilo is superior to using Medicult IVM for In vitro maturation. …
Phase 3 • Sponsor: Gameto, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
AI could help predict which IVF treatments work best
Knowledge-focused OngoingInfertility, as defined by the World Health Organization (WHO), is a disorder of the male or female reproductive system characterized by the inability to achieve a clinical pregnancy after 12 months or more of regular, unprotected sexual intercourse. In modern fertility treatment…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New depression pill shows promise in Long-Term safety trial
Symptom relief Recruiting nowThis study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.
Phase 3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New ultrasound technique could sharpen heart arrhythmia diagnosis
Diagnosis By invitation onlyAtrial and ventricular cardiac arrhythmias are serious public health problems in the United States, affecting over 5% of Americans and are major causes of stroke and heart failure leading to increased morbidity and mortality. This proposed clinical trial will determine how electr…
Sponsor: Columbia University • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
PRP and a daily pill: a new combo for ED?
Disease control CompletedPlatelet-rich plasma is being studied as a regenerative treatment option for erectile dysfunction, but it is unclear whether adding daily tadalafil gives additional benefit over platelet-rich plasma alone. This study evaluates adult men with mild to mild-moderate erectile dysfunc…
Phase 4 • Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New steroid test may spot hidden cause of high blood pressure without risky drug changes
Diagnosis Recruiting nowThis prospective, single-center observational study aims to evaluate whether a steroid-based screening method can more accurately identify Primary Aldosteronism (PA) in hypertensive patients who remain on their usual antihypertensive medications, compared with the conventional al…
Sponsor: Qifu Li • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New hope for advanced cancer? first human trial of HS-20122 begins
Disease control Recruiting nowThis is a first-in-human (FIH) Phase I, multi-center, open-label, study of HS-20122, in patients with advanced solid tumors. This study will evaluate the safety, tolerability, pharmacokinetics and efficacy of HS-20122 in advanced solid tumors.
Phase 1 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a new Omega-3 molecule bypass fat digestion?
Knowledge-focused Completed* Omega-3 fatty acids such as docosahexaenoic acid (DHA) have well-established health benefits and are widely used to improve cardiometabolic health. However, conventional DHA supplements require normal digestion and absorption of dietary fat, which may limit their effectiveness …
Sponsor: University of Copenhagen • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC